A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases

Clinical trial NCT07167537 · RECRUITING

Trial details

NCT number: NCT07167537
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)Primary Sjogren's Syndrome

Start date: 2025-10-01
Primary completion: 2027-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.